dc.contributor.author |
Tenorio Mucha, Janeth Marilyn |
|
dc.contributor.author |
Busta Flores, Patricia Janet |
|
dc.contributor.author |
Lazo Porras, María de los Ángeles |
|
dc.contributor.author |
Vetter, Beatrice |
|
dc.contributor.author |
Safary, Elvis |
|
dc.contributor.author |
Moran, Andrew E. |
|
dc.contributor.author |
Gupta, Reena |
|
dc.contributor.author |
Bernabé Ortiz, Antonio |
|
dc.date.accessioned |
2023-05-19T14:08:33Z |
|
dc.date.available |
2023-05-19T14:08:33Z |
|
dc.date.issued |
2023 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/13518 |
|
dc.description.abstract |
BACKGROUND: Point-of-care testing (POCT) devices may facilitate the delivery of rapid and timely results, providing a clinically important advantage in patient management. The challenges and constraints in the implementation process, considering different levels of actors have not been much explored. This scoping review aimed to assess literature pertaining to implementation facilitators and barriers of POCT devices for the diagnosis or monitoring of cardiometabolic diseases. METHODS: A scoping review of the literature was conducted. The inclusion criteria were studies on the inception, planning, or implementation of interventions with POCT devices for the diagnosis or monitoring of cardiometabolic diseases defined as dyslipidemia, cardiovascular diseases, type 2 diabetes, and chronic kidney disease. We searched MEDLINE, Embase, and Global Health databases using the OVID searching engine until May 2022. The Consolidated Framework of Implementation Research (CFIR) was used to classify implementation barriers and facilitators in five constructs. Also, patient, healthcare professional (HCP), and organization level was used. RESULTS: Twenty studies met the eligibility criteria for data extraction. All studies except two were conducted in high-income countries. Some findings are: 1) Intervention: the most widely recognized facilitator was the quick turnaround time with which results are obtained. 2) Outer setting: at the organizational level, the lack of clear regulatory and accreditation mechanisms has hindered the adoption and sustainability of the use of POCT. 3) Inner setting: for HCP, performing POCT during the consultation was both a facilitator and a barrier in terms of time, personnel, and service delivery. 4) Individuals: the implementation of POCT may generate stress and discomfort in some HCP in terms of training and new responsibilities. 5) Process: for patients, it is highly appreciated that obtaining the sample was simple and more comfortable if venipuncture was not used. CONCLUSION: This scoping review has described the facilitators and barriers of implementing a POCT device for cardiometabolic conditions using the CFIR. The information can be used to design better strategies to implement these devices and benefit more populations that have low access to cardiometabolic tests. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
BioMed Central |
|
dc.relation.ispartofseries |
BMC Health Services Research |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Point-of-care testing |
en_US |
dc.subject |
Noncommunicable diseases |
en_US |
dc.subject |
Chronic disease |
en_US |
dc.subject |
Metabolic syndrome |
en_US |
dc.subject |
Implementation science |
en_US |
dc.subject.mesh |
Pruebas en el Punto de Atención |
|
dc.subject.mesh |
Enfermedades no Transmisibles |
|
dc.subject.mesh |
Enfermedad Crónica |
|
dc.subject.mesh |
Síndrome Metabólico |
|
dc.subject.mesh |
Ciencia de la Implementación |
|
dc.title |
Facilitators and barriers of the implementation of point-of-care devices for cardiometabolic diseases: a scoping review. |
en_US |
dc.type |
info:eu-repo/semantics/review |
|
dc.identifier.doi |
https://doi.org/10.1186/s12913-023-09419-2 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.02 |
|
dc.relation.issn |
1472-6963 |
|